NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Public Health Agency Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD WHITE | — |
Health Issues HCR
Health issues impacting patients with rare diseases. Rare disease initiatives. Telehealth. Step Therapy. H.R.2279/S.2546: Safe Step Act. Newborn screening. Genetic testing. Health equity. Affordable Care Act (ACA) issues. Affordable Care Act (ACA) enhancements. Drug Pricing and Orphan Drug Act. COVID-19 Related Issues. Medical Nutrition.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CORINNE ALBERTS | — |
| ROSE AVELLINO GALLAGHER | — |
| HEIDI ROSS | — |
| RICHARD WHITE New | — |
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases. Medicare Part D Program. Section 1115 Medicaid Waivers. Medicaid Drug Rebates. Prescription Drug Pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CORINNE ALBERTS | — |
| ROSE AVELLINO GALLAGHER | — |
| HEIDI ROSS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.